Merck (MRK) Tops Q4 EPS by 1c

Merck (NYSE: MRK) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $10.48 billion versus the consensus estimate of $10.61 billion.

Merck sees FY2015 EPS of $3.32-$3.47, versus the consensus of $3.49.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
• UBS cuts KOSPI target by nearly 10% to reflect higher rates